Onyx Pharmaceuticals Inc on Sunday confirmed it had rejected an offer from Amgen Inc to buy the company for $120 a share in cash. The company said that the offer price "significantly undervalued" ...
via Business & Finance News - Yahoo! Finance http://finance.yahoo.com/news/onyx-pharma-rejects-buyout-offer-163328843.html
via Business & Finance News - Yahoo! Finance http://finance.yahoo.com/news/onyx-pharma-rejects-buyout-offer-163328843.html
0 commentaires:
Enregistrer un commentaire